Hallahan DE - Search Results

1

Targeting a Radiosensitizing Antibody-Drug Conjugate to a Radiation-Inducible Antigen.

Lewis CD, Singh AK, Hsu FF, Thotala D, Hallahan DE, Kapoor V. Lewis CD, et al. Among authors: hallahan de. Clin Cancer Res. 2021 Jun 1;27(11):3224-3233. doi: 10.1158/1078-0432.CCR-20-1725. Clin Cancer Res. 2021. PMID: 34074654 Free PMC article.

2

Gene therapy targeted by radiation preferentially radiosensitizes tumor cells.

Weichselbaum RR, Hallahan DE, Beckett MA, Mauceri HJ, Lee H, Sukhatme VP, Kufe DW. Weichselbaum RR, et al. Among authors: hallahan de. Cancer Res. 1994 Aug 15;54(16):4266-9. Cancer Res. 1994. PMID: 8044769

3

Role of gene therapy in radiation oncology.

Hallahan DE, Weichselbaum R. Hallahan DE, et al. Cancer Treat Res. 1998;93:153-67. doi: 10.1007/978-1-4615-5769-2_7. Cancer Treat Res. 1998. PMID: 9513780 Review. No abstract available.

4

Radiation-mediated control of drug delivery.

Hallahan DE, Qu S, Geng L, Cmelak A, Chakravarthy A, Martin W, Scarfone C, Giorgio T. Hallahan DE, et al. Am J Clin Oncol. 2001 Oct;24(5):473-80. doi: 10.1097/00000421-200110000-00012. Am J Clin Oncol. 2001. PMID: 11586099 Review.

5

A specific antagonist of the p110delta catalytic component of phosphatidylinositol 3'-kinase, IC486068, enhances radiation-induced tumor vascular destruction.

Geng L, Tan J, Himmelfarb E, Schueneman A, Niermann K, Brousal J, Fu A, Cuneo K, Kesicki EA, Treiberg J, Hayflick JS, Hallahan DE. Geng L, et al. Among authors: hallahan de. Cancer Res. 2004 Jul 15;64(14):4893-9. doi: 10.1158/0008-5472.CAN-03-3955. Cancer Res. 2004. PMID: 15256460

6

Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma.

Shinohara ET, Gonzalez A, Massion PP, Chen H, Li M, Freyer AS, Olson SJ, Andersen JJ, Shyr Y, Carbone DP, Johnson DH, Hallahan DE, Lu B. Shinohara ET, et al. Among authors: hallahan de. Cancer. 2005 Apr 15;103(8):1685-92. doi: 10.1002/cncr.20951. Cancer. 2005. PMID: 15742356 Free article.

7

DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs.

Shinohara ET, Geng L, Tan J, Chen H, Shir Y, Edwards E, Halbrook J, Kesicki EA, Kashishian A, Hallahan DE. Shinohara ET, et al. Among authors: hallahan de. Cancer Res. 2005 Jun 15;65(12):4987-92. doi: 10.1158/0008-5472.CAN-04-4250. Cancer Res. 2005. PMID: 15958537

8

Inhibition of alpha(v)beta3 integrin survival signaling enhances antiangiogenic and antitumor effects of radiotherapy.

Abdollahi A, Griggs DW, Zieher H, Roth A, Lipson KE, Saffrich R, Gröne HJ, Hallahan DE, Reisfeld RA, Debus J, Niethammer AG, Huber PE. Abdollahi A, et al. Among authors: hallahan de. Clin Cancer Res. 2005 Sep 1;11(17):6270-9. doi: 10.1158/1078-0432.CCR-04-1223. Clin Cancer Res. 2005. PMID: 16144931

9

Radiation-guided gene therapy of cancer.

Han Z, Wang H, Hallahan DE. Han Z, et al. Among authors: hallahan de. Technol Cancer Res Treat. 2006 Aug;5(4):437-44. doi: 10.1177/153303460600500412. Technol Cancer Res Treat. 2006. PMID: 16866574 Free article. Review.

10

Lithium treatment prevents neurocognitive deficit resulting from cranial irradiation.

Yazlovitskaya EM, Edwards E, Thotala D, Fu A, Osusky KL, Whetsell WO Jr, Boone B, Shinohara ET, Hallahan DE. Yazlovitskaya EM, et al. Among authors: hallahan de. Cancer Res. 2006 Dec 1;66(23):11179-86. doi: 10.1158/0008-5472.CAN-06-2740. Cancer Res. 2006. PMID: 17145862

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

219 results

Search Page